We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$81B
AUM Growth
-$1.58B
Cap. Flow
-$3.65B
Cap. Flow %
-4.5%
Top 10 Hldgs %
16.13%
Holding
1,955
New
98
Increased
953
Reduced
772
Closed
100

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$786M
2
ABEV icon
Ambev
ABEV
+$368M
3
AAPL icon
Apple
AAPL
+$331M
4
BIDU icon
Baidu
BIDU
+$323M
5
JNJ icon
Johnson & Johnson
JNJ
+$285M

Sector Composition

Rank Sector Weight
1 Energy 15.38%
2 Financials 14.63%
3 Consumer Discretionary 13.36%
4 Healthcare 12.27%
5 Technology 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMBS icon
1726
Rambus
RMBS
$10.4B
$281K ﹤0.01%
24,623
+3,549
+17% +$43.6K
CAMP
1727
DELISTED
CalAmp Corp.
CAMP
$279K ﹤0.01%
597
-73
-11% -$31K
TCBI icon
1728
Texas Capital Bancshares
TCBI
$4.31B
$278K ﹤0.01%
3,585
-311,045
-99% -$24M
AMH icon
1729
American Homes 4 Rent
AMH
$12B
$276K ﹤0.01%
12,210
-1,335,905
-99% -$30.4M
FULT icon
1730
Fulton Financial
FULT
$4.7B
$276K ﹤0.01%
14,506
+900
+7% +$16.4K
LNTH icon
1731
Lantheus
LNTH
$6.82B
$273K ﹤0.01%
+15,448
New +$227K
EPAY
1732
DELISTED
Bottomline Technologies Inc
EPAY
$273K ﹤0.01%
10,638
-449
-4% -$11K
CVBF icon
1733
CVB Financial
CVBF
$3.98B
$272K ﹤0.01%
12,150
+682
+6% +$14.6K
USPH icon
1734
US Physical Therapy
USPH
$1.14B
$271K ﹤0.01%
4,493
+757
+20% +$48.4K
BIVV
1735
DELISTED
Bioverativ Inc. Common Stock
BIVV
$270K ﹤0.01%
4,491
-159,782
-97% -$9.1M
FFIV icon
1736
F5
FFIV
$22.1B
$269K ﹤0.01%
2,117
+412
+24% +$54K
TTSH
1737
DELISTED
Tile Shop Holdings
TTSH
$269K ﹤0.01%
13,015
-802
-6% -$16.3K
CHEF icon
1738
Chefs' Warehouse
CHEF
$3.87B
$267K ﹤0.01%
20,569
-155
-0.7% -$2.23K
RAMP icon
1739
LiveRamp
RAMP
$2.29B
$267K ﹤0.01%
10,307
+1,199
+13% +$32.6K
VECO icon
1740
Veeco
VECO
$3.15B
$267K ﹤0.01%
9,608
+505
+6% +$15.5K
FARO
1741
DELISTED
Faro Technologies
FARO
$266K ﹤0.01%
7,032
-89
-1% -$3.16K
VRSK icon
1742
Verisk Analytics
VRSK
$26.4B
$266K ﹤0.01%
3,150
+106
+3% +$8.58K
POLY
1743
DELISTED
Plantronics, Inc.
POLY
$266K ﹤0.01%
5,080
+216
+4% +$11.6K
MUR icon
1744
Murphy Oil
MUR
$5.58B
$265K ﹤0.01%
10,348
+2,144
+26% +$56K
WCC
1745
WESCO International
WCC
$16.2B
$263K ﹤0.01%
4,593
-416
-8% -$25.8K
IDTI
1746
DELISTED
Integrated Device Technology I
IDTI
$262K ﹤0.01%
10,145
-70
-0.7% -$1.7K
KN icon
1747
Knowles
KN
$3.22B
$260K ﹤0.01%
15,378
+1,918
+14% +$34.5K
PRLB icon
1748
Protolabs
PRLB
$1.86B
$259K ﹤0.01%
3,846
-859
-18% -$51.9K
VRTS icon
1749
Virtus Investment Partners
VRTS
$1.11B
$259K ﹤0.01%
2,329
+41
+2% +$4.35K
AGM icon
1750
Federal Agricultural Mortgage
AGM
$2.27B
$256K ﹤0.01%
+3,962
New +$240K

Similar funds

OppenheimerFunds's Q2 2017 Portfolio in Review

As of Q2 2017, OppenheimerFunds held 1,955 positions worth $81B, down 1.9% from $82.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

OppenheimerFunds withdrew a net $3.65B in Q2 2017, closing 100 positions and reducing 772 holdings. Its most notable exit was Energy Transfer Partners L.p., an estimated $786M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, OppenheimerFunds opened a new position in Antero Midstream worth $132M.

  • OppenheimerFunds's largest Q2 2017 buy was Antero Midstream: 5,990,120 shares worth $132M.
  • OppenheimerFunds added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $729M increase.
  • OppenheimerFunds's biggest Q2 2017 reduction was Apple, cutting an estimated $331M.
  • OppenheimerFunds fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $786M.
  • OppenheimerFunds's ten largest holdings make up 16% of its $81B portfolio in Q2 2017.
  • OppenheimerFunds opened 98 new positions and closed 100 in Q2 2017.
  • OppenheimerFunds's portfolio value fell 1.9% quarter-over-quarter to $81B.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.